Laboratory Corporation of America Holdings
Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients

Abstract:

The present invention relates generally to methods of accurately quantifying HER2 and/or p95 expression in subjects with a HER2 positive cancer and indicating the risk of brain relapse in such patients.